Upgrade to SI Premium - Free Trial

Intelligent Bio Solutions (INBS)

2.23 -0.07 (3.04%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Intelligent Bio Solutions reports 98% accuracy in drug screening study September 1, 2026 8:31 AM - StreetInsider Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission September 1, 2026 8:31 AM - StreetInsider Intelligent Bio Solutions raises $5M in private placement September 1, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules September 1, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth August 19, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions wins ISO 13485 recertification for drug screening August 17, 2026 8:31 AM - StreetInsider Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification August 17, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions completes drug screening clinical study August 11, 2026 8:32 AM - StreetInsider Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System August 11, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions completes usability study for FDA submission August 5, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission August 5, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System August 3, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions clears cybersecurity items for FDA 510(k) filing July 23, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry July 23, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions completes precision testing for FDA submission July 21, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market July 21, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions starts interference study for FDA drug screening submission June 16, 2026 8:30 AM - StreetInsider Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry June 16, 2026 8:30 AM - StreetInsider Full Article List